Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana
- PMID: 30608931
- PMCID: PMC6342320
- DOI: 10.1371/journal.pntd.0006994
Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana
Abstract
Background: Despite the progress achieved in scaling-up mass drug administration (MDA) for lymphatic filariasis (LF) in Ghana, communities with persistent LF still exist even after 10 years of community treatment. To understand the reasons for persistence, we conducted a study to assess the status of disease elimination and understand the adherence to interventions including MDA and insecticide treated nets.
Methodology and principal findings: We conducted a parasitological and epidemiological cross-sectional study in adults from eight villages still under MDA in the Northern Region savannah and the coastal Western Region of the country. Prevalence of filarial antigen ranged 0 to 32.4% and in five villages the prevalence of night blood microfilaria (mf) was above 1%, ranging from 0 to 5.7%. Median mf density was 67 mf/ml (range: 10-3,560). LF antigen positivity was positively associated with male sex but negatively associated with participating in MDA the previous year. Male sex was also associated with a decreased probability of participating in MDA. A stochastic model (TRANSFIL) was used to assess the expected microfilaria prevalence under different MDA coverage scenarios using historical data on one community in the Western Region. In this example, the model simulations suggested that the slow decline in mf prevalence is what we would expect given high baseline prevalence and a high correlation between MDA adherence from year to year, despite high MDA coverage.
Conclusions: There is a need for an integrated quantitative and qualitative research approach to identify the variations in prevalence, associated risk factors and intervention coverage and use levels between and within regions and districts. Such knowledge will help target resources and enhance surveillance to the communities most at risk and to reach the 2020 LF elimination goals in Ghana.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
How Thailand eliminated lymphatic filariasis as a public health problem.Infect Dis Poverty. 2019 May 27;8(1):38. doi: 10.1186/s40249-019-0549-1. Infect Dis Poverty. 2019. PMID: 31130143 Free PMC article.
-
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New Guinea.PLoS Negl Trop Dis. 2025 Jan 27;19(1):e0012128. doi: 10.1371/journal.pntd.0012128. eCollection 2025 Jan. PLoS Negl Trop Dis. 2025. PMID: 39869653 Free PMC article.
-
Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.PLoS Negl Trop Dis. 2024 Jun 27;18(6):e0012236. doi: 10.1371/journal.pntd.0012236. eCollection 2024 Jun. PLoS Negl Trop Dis. 2024. PMID: 38935622 Free PMC article.
-
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.Cochrane Database Syst Rev. 2019 Jan 8;1(1):CD003753. doi: 10.1002/14651858.CD003753.pub4. Cochrane Database Syst Rev. 2019. PMID: 30620051 Free PMC article.
-
The role of albendazole in programmes to eliminate lymphatic filariasis.Parasitol Today. 1999 Sep;15(9):382-6. doi: 10.1016/s0169-4758(99)01486-6. Parasitol Today. 1999. PMID: 10461168 Review.
Cited by
-
Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana.PLoS Negl Trop Dis. 2022 Aug 4;16(8):e0010129. doi: 10.1371/journal.pntd.0010129. eCollection 2022 Aug. PLoS Negl Trop Dis. 2022. PMID: 35926012 Free PMC article.
-
Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014.Parasit Vectors. 2020 Mar 12;13(1):125. doi: 10.1186/s13071-020-3996-4. Parasit Vectors. 2020. PMID: 32164780 Free PMC article.
-
Targeting a highly repetitive genomic sequence for sensitive and specific molecular detection of the filarial parasite Mansonella perstans from human blood and mosquitoes.PLoS Negl Trop Dis. 2022 Dec 29;16(12):e0010615. doi: 10.1371/journal.pntd.0010615. eCollection 2022 Dec. PLoS Negl Trop Dis. 2022. PMID: 36580452 Free PMC article.
-
Sociodemographic characteristics as predictors of knowledge regarding mode of transmission of Lymphatic Filariasis among population of Nepal.PLOS Glob Public Health. 2022 Oct 11;2(10):e0000082. doi: 10.1371/journal.pgph.0000082. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962552 Free PMC article.
-
Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.PLoS One. 2020 Apr 13;15(4):e0231541. doi: 10.1371/journal.pone.0231541. eCollection 2020. PLoS One. 2020. PMID: 32282840 Free PMC article.
References
-
- World Health Organization. Investing to overcome the global impact of neglected tropical diseases—Third WHO report on neglected tropical diseases [Internet]. Geneva: World Health Organization; 2015. Available: http://www.who.int/neglected_diseases
-
- World Health Organization. Lymphatic filariasis: a handbook of practical entomology for national lymphatic filariasis elimination programmes [Internet]. Geneva: World Health Organization; 2013. Available: http://www.who.int/lymphatic_filariasis/en/
-
- World Health Organization. Progress report 2000–2009 and strategic plan 2010–2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic fi lariasis. [Internet]. Geneva: World Health Organization; 2010. Available: http://www.who.int/lymphatic_filariasis/resources/annual_reports/en/
-
- World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec. 2016;91: 441–460. Available: http://www.who.int/wer - PubMed
-
- World Health Organization. Global Programme to Eliminate Lymphatic Filariasis: Monitoring and Epidemiological Assessment of Mass Drug Administration. Geneva; 2011.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources